Patients’ characteristics | Non-Qatari (61 patients) | Qatari (36 patients) | P-value |
---|---|---|---|
Demography | Â | Â | Â |
Gender (Male) | 43 (71.1) | 17 (28.3%) | 0.033 |
Age | 62.10 ± 15.368 | 75.89 ± 11.506 | 0.001 |
BMI | 28.1226 ± 6.76984 | 30.2086 ± 6.41 | 0.138 |
Comorbidities and risk | Â | Â | Â |
DM | 37 (60.6%) | 31 (86.1%) | 0.008 |
HTN | 46 (75.4) | 35 (97.2) | 0.005 |
CAD | 31 (50.8%) | 23 (63.9%) | 0.211 |
CKD | 14 (23.0%) | 12 (33.3%) | 0.265 |
Asthma | 6 (9.8%) | 4 (11.1%) | 0.842 |
CLD | 5 (8.2%) | 1 (2.8%) | 0.284 |
AKI requiring dialysis | 15 (24.6%) | 10 (27.8%) | 0.729 |
CCI | 3.54 ± 2.37 | 5.62 ± 2.15 | 0.001 |
Malignancy | 5 (8.2%) | 3 (8.3%) | 0.981 |
Septic shock | 20 (32.8%) | 9 (25.0%) | 0.418 |
History of abdominal surgery | 7 (53.8%) | 6 (46.2%) | 0.468 |
ASA score (≥ 3) | 51 (85%) | 35 (97.2%) | 0.079 |
Radiology | |||
US | 47 (77.0%) | 32 (88.9%) | 0.147 |
Need for CT scan | 25 (41.0%) | 14 (38.9%) | 0.839 |
Need for MRI/MRCP | 15 (24.6%) | 3 (8.3%) | 0.047 |
Laboratory | |||
WBCS | 17.92 ± 10.71 | 17.02 ± 8.48 | 0.670 |
HGB | 11.35 ± 2.38 | 10.88 ± 2.25 | 0.339 |
PLT | 254.48 ± 136.79 | 271.58 ± 140.84 | 0.558 |
Neutrophil | 14.35 ± 7.63 | 12.63 ± 7.59 | 0.284 |
Lymphocyte | 2.15 ± 7.38 | 1.55 ± 1.12 | 0.631 |
INR | 1.39 ± 0.59 | 1.48 ± 1.32 | 0.664 |
BUN | 9.39 ± 8.3 | 9.96 ± 5.72 | 0.717 |
Cr | 155.55 ± 208.35 | 164.33 ± 137.25 | 0.822 |
NA | 135.21 ± 4.43 | 134.89 ± 6.03 | 0.780 |
K | 4.76 ± 4.39 | 5.19 ± 6.38 | 0.691 |
BIL T | 34.85 ± 45.97 | 31.82 ± 49.49 | 0.761 |
BIL D | 52.23 ± 50.61 | 61.49 ± 64.33 | 0.673 |
ALB | 26.85 ± 8.21 | 26.28 ± 6.76 | 0.728 |
ALK | 194.18 ± 192.5 | 187.28 ± 132.02 | 0.850 |
ALT | 66.09 ± 102.07 | 94.8 ± 197.41 | 0.350 |
AST | 86.08 ± 157.03 | 131.3 ± 278.76 | 0.319 |
CRP | 198.13 ± 139.94 | 178.51 ± 120.94 | 0.493 |
Serum Lactate | 2.7 ± 2.16 | 2.82 ± 1.97 | 0.809 |
Procalcitonin | 14.38 ± 22.71 | 10.43 ± 21.84 | 0.509 |
TG 18 | 0.750 | ||
Grade 1 | 17 (34.0%) | 9 (32.1%) | |
Grade II | 27 (54%) | 17 (60.7%) | |
Grade III | 6 (12%) | 2 (7.1%) | |
Hospital Course and Outcomes | |||
ICU admission | 31 (50.8%) | 17 (47.2%) | 0.732 |
ICU stay (days) | 12.07 ± 15.03 | 18.56 ± 32.31 | 0.355 |
LOS (days) | 26.4918 ± 27.33412 | 32.3056 ± 35.77934 | 0.370 |
Follow up (days) | 469.32 ± 551.02 | 750.61 ± 639.66 | 0.024 |
30-day readmission | 8 (13.6%) | 6 (16.7%) | 0.679 |
Number of PC catheter insertions | 2 ± 0 | 3 ± 1.7 | 0.423 |
PC complications | 7 (77.8%) | 2 (22.2%) | 0.332 |
Overall Mortalities | 19 (57.6%) | 14 (42.4) | 0.437 |